High speed and adaptable error correction for megabit/s rate quantum key distribution

por Dixon, A. R., Sato, H.
Publicado 2014

A randomised trial of second-line hormone vs single agent chemotherapy in tamoxifen resistant advanced breast cancer.

por Dixon, A. R., Jackson, L., Chan, S., Haybittle, J., Blamey, R. W.
Publicado 1992

A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinomas of the breast.

por Dixon, A. R., Ellis, I. O., Elston, C. W., Blamey, R. W.
Publicado 1991

Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?

por Dixon, A. R., Jackson, L., Chan, S. Y., Badley, R. A., Blamey, R. W.
Publicado 1993

P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy.

por Dixon, A. R., Bell, J., Ellis, I. O., Elston, C. W., Blamey, R. W.
Publicado 1992

Epithelial mucin core antigen (EMCA) in assessing therapeutic response in advanced breast cancer--a comparison with CA15.3.

por Dixon, A. R., Price, M. R., Hand, C. W., Sibley, P. E., Selby, C., Blamey, R. W.
Publicado 1993

Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.

por Dixon, A. R., Robertson, J. F., Jackson, L., Nicholson, R. I., Walker, K. J., Blamey, R. W.
Publicado 1990

VEGF(165)b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has...

por Varey, A H R, Rennel, E S, Qiu, Y, Bevan, H S, Perrin, R M, Raffy, S, Dixon, A R, Paraskeva, C, Zaccheo, O, Hassan, A B, Harper, S J, Bates, D O
Publicado 2008

Quantum key distribution with hacking countermeasures and long term field trial

por Dixon, A. R., Dynes, J. F., Lucamarini, M., Fröhlich, B., Sharpe, A. W., Plews, A., Tam, W., Yuan, Z. L., Tanizawa, Y., Sato, H., Kawamura, S., Fujiwara, M., Sasaki, M., Shields, A. J.
Publicado 2017